Perceived Changes in Anxiety Symptom Burden During Treatment with Bryophyllum pinnatum: A Prospective, Single-Arm Study
The results suggest that Bryophyllum 50% chewable tablets have beneficial effects on anxiety-related symptoms. Since the study design does not allow us to conclude causality between treatment and observed improvements, a randomized clinical trial is urgently needed.
Authors
- Markus Schlemmer
- Daniel Krüerke (ORCID: https://orcid.org/0000-0002-3600-0403)
- Ana Paula Simões‐Wüst (ORCID: https://orcid.org/0000-0002-4489-0952)
- Markus Weber (ORCID: https://orcid.org/0000-0002-5538-9274)
- T Huber
- Matthias Kröz
- Timotheus Haeck
Institutions
- Witten/Herdecke University (DE)
- University of Zurich (CH)
- University Hospital of Zurich (CH)
- Forschungsinstitut Havelhöhe (DE)
- Verein für Krebsforschung (CH)
Publication Details
- Journal
- Pharmaceuticals
- Published
- 2024-10-24
- DOI
- https://doi.org/10.3390/ph17111423
- Citations
- 3
- Primary Topic
- Olfactory and Sensory Function Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.08